Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

NCT07327489 is registered in ClinicalTrials.gov with Elephas as lead sponsor.

NCT NCT07327489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07327489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Lead sponsor
Elephas
Phase
Observational
Overall status
Recruiting
Start date
April 14, 2025
Completion date
April 30, 2038
Enrollment
2,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors cancer, bladder cancer, cancer, colorectal cancer, dmmr colorectal cancer, endometrial cancer, head and neck cancer, immunotherapy, kidney cancer, liver cancer, melanoma (skin cancer), msi-h colorectal cancer, nsclc (non-small-cell lung cancer), skin cancer, tnbc, triple negative breast cancer